Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2
Bio Nebraska member, Pfizer, and BioNTech announced preliminary data from the most advanced of four investigational vaccine candidates from their BNT162 mRNA-based vaccine program.
University of Nebraska among world’s top 100 in earning U.S. patents
For the third straight year, the University of Nebraska system is ranked among the top 100 academic institutions worldwide in earning U.S. patents.
Bio Nebraska Members Can Save Money at Office Depot
Attention Bio Nebraska Members! Save Money at Office Depot when you enroll in the BIO Business Solutions® Cost Savings Program.
Merck Animal Health Completes Acquisition of Quantified Ag®
Merck Animal Health announced the completion of its acquisition of Lincoln-based Quantified Ag®, a leading data and analytics company that monitors cattle body temperature and movement in order to detect illness early.
Renewable Fuels Month Spotlights Benefits of Homegrown Fuel Options
To help promote locally-produced biofuels, such as ethanol and biodiesel, Nebraska Gov. Pete Ricketts recently declared June as Renewable Fuels Month.
The Future of Pharmacy: Celerion Expands Its Purpose-Built, USP-Compliant Pharmacy Capabilities Across Facilities
Bio Nebraska member, Celerion, announces expansion of specialized pharmacies across their clinical research units in North America.
Member Spotlight: BWBR
BWBR, a design solutions firm with cutting edge architecture, interior design, and master planning expertise, believes that resilient design will take on a new and different imperative in a world reshaped by this pandemic.
ProTransit Nanotherapy to launch clinical trials combating the precursors of skin cancer
Bio Nebraska member, ProTransit Nanotherapy, will launch human clinical trials this summer with products that could help prevent and, in some cases, improve sunspots and neutralize free radicals, both precursors to skin cancer.
Bio Nebraska and Members Featured in Lincoln Journal Star
An op-ed by Rob Owen, our executive director, was published in the Lincoln Journal Star about our state’s bioscience sector stepping up during the age of coronavirus.
Adjuvance Technologies Announces NIH Funding for COVID-19 Vaccine Research
Adjuvance Technologies Inc., a member of Bio Nebraska, announced that they have been awarded supplemental contract funding from the National Institute of Allergy and Infectious Diseases (NIAID).